Active Repurposing of Drug Candidates for Melanoma Based on GWAS, PheWAS and a Wide Range of Omics Data

Molecular Medicine - United States
doi 10.1186/s10020-019-0098-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Drug Candidates for Bipolar Disorder – A Nation‐wide Population‐based Study

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2019English

Construction of an miRNA-regulated Drug-Pathway Network Reveals Drug Repurposing Candidates for Myasthenia Gravis

International Journal of Molecular Medicine
MedicineGenetics
2017English

A Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2017English

A Genome-Wide Survey for SNPs Altering microRNA Seed Sites Identifies Functional Candidates in GWAS

BMC Genomics
BiotechnologyGenetics
2011English

New Drug Candidates for Treatment of Atypical Meningiomas: An Integrated Approach Using Gene Expression Signatures for Drug Repurposing

PLoS ONE
Multidisciplinary
2018English

Refinement of Schizophrenia GWAS Loci Using Methylome-Wide Association Data

Human Genetics
Genetics
2014English

On Sharing Quantitative Trait GWAS Results in an Era of Multiple-Omics Data and the Limits of Genomic Privacy

American Journal of Human Genetics
Genetics
2012English

GWAS and Drug Targets

BMC Genomics
BiotechnologyGenetics
2014English

In Silicomethods for Drug Repurposing and Pharmacology

Wiley Interdisciplinary Reviews: Systems Biology and Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy